Wire · regulatory
Pesticide Giant Reaches $35 Million Antitrust Deal With FTC
◆ Sectors
Medtech
◆ Geography
United States
◆ Source
◆ Verified
Fusion42 · 5 October 2026 · Fusion42 review
A federal appeals court revived antitrust claims against Align Technology, maker of Invisalign, allowing class actions to proceed over allegations it restricted competition by ending interoperability with a rival scanner brand and using exclusionary practices.
This Wire brief sits within Fusion42's coverage of Medtech.
◆ ◆ The Wire takeaway
You face a regulatory risk as courts signal tougher scrutiny on anticompetitive conduct by dominant players in Medtech. Align’s battle shows that defending exclusivity can backfire and open paths for rivals to capture abandoned market segments.
◆ Coverage
1 source · 5 Oct 2026
◆ Related on Wire
◆ Topics
Medtechantitrustlitigationmedtechmarket-competitioninteroperability